SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-004614
Filing Date
2017-03-16
Accepted
2017-03-16 16:06:32
Documents
62
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fate-10k_20161231.htm 10-K 2970570
2 EX-21.1 fate-ex211_152.htm EX-21.1 14486
3 EX-23.1 fate-ex231_9.htm EX-23.1 4716
4 EX-31.1 fate-ex311_11.htm EX-31.1 9806
5 EX-32.1 fate-ex321_6.htm EX-32.1 6936
6 GRAPHIC g2017031518182007540616.jpg GRAPHIC 29613
  Complete submission text file 0001564590-17-004614.txt   9672259

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fate-20161231.xml EX-101.INS 2080209
8 XBRL TAXONOMY EXTENSION SCHEMA fate-20161231.xsd EX-101.SCH 55439
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fate-20161231_cal.xml EX-101.CAL 64643
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fate-20161231_def.xml EX-101.DEF 237735
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20161231_lab.xml EX-101.LAB 501856
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20161231_pre.xml EX-101.PRE 380541
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36076 | Film No.: 17694523
SIC: 2836 Biological Products, (No Diagnostic Substances)